JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

Search

Aytu BioScience Inc

Abierto

2.33 4.95

Resumen

Variación precio

24h

Actual

Mínimo

2.24

Máximo

2.37

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+256.11% upside

Aytu BioScience Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 feb 2026, 00:00 UTC

Acciones populares

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 feb 2026, 22:55 UTC

Ganancias

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 feb 2026, 21:44 UTC

Ganancias

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 feb 2026, 21:39 UTC

Ganancias

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 feb 2026, 00:00 UTC

Ganancias

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 feb 2026, 00:00 UTC

Ganancias

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 feb 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 feb 2026, 23:45 UTC

Ganancias

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 feb 2026, 23:32 UTC

Charlas de Mercado

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 feb 2026, 22:59 UTC

Adquisiciones, fusiones, absorciones

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 feb 2026, 22:30 UTC

Ganancias

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 feb 2026, 22:30 UTC

Ganancias

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 feb 2026, 22:21 UTC

Ganancias

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 22:17 UTC

Charlas de Mercado

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 feb 2026, 22:15 UTC

Charlas de Mercado

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 feb 2026, 22:00 UTC

Charlas de Mercado

ESG Roundup: Market Talk

4 feb 2026, 21:53 UTC

Ganancias

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 feb 2026, 21:51 UTC

Ganancias

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 feb 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

4 feb 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

4 feb 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

4 feb 2026, 21:45 UTC

Ganancias

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 feb 2026, 21:44 UTC

Ganancias

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 feb 2026, 21:43 UTC

Ganancias

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 feb 2026, 21:41 UTC

Ganancias

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb 2026, 21:36 UTC

Charlas de Mercado

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 feb 2026, 21:30 UTC

Ganancias

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Ganancias

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Ganancias

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparación entre iguales

Cambio de precio

Aytu BioScience Inc previsión

Precio Objetivo

By TipRanks

256.11% repunte

Estimación a 12 Meses

Media 9.33 USD  256.11%

Máximo 13 USD

Mínimo 7 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aytu BioScience Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Finanzas

$

help-icon Live chat